Unicycive Therapeutics, Inc.
UNCY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001766140
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
79
- +28 vs. Q1 2026
- Total value $61.36M
Superinvestors holding UNCY
0
- None of the superinvestors held UNCY at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by UNCY insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2022 | May 16, 2022 | Schiller BrigitteDirector | PPurchaseCommon Stock | +15K | $0.83 | +$12.45K | 15K | New position | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in UNCY at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 2,802,894 | $13.15M | 0.40% | +1,863,692+198.4% | Added |
| BlackRock, Inc. | 1,413,381 | $6.63M | 0.00% | +1,377,478+3,836.7% | Added |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,071,481 | $5.03M | 0.00% | +260,051+32.0% | Added |
| Octagon Capital Advisors LP | 1,000,000 | $4.69M | 0.43% | 00.0% | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | 564,019 | $2.65M | 0.00% | +360,275+176.8% | Added |